+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

United States Respiratory Measurement Devices Market Outlook to 2025

  • ID: 4663380
  • Report
  • October 2018
  • Region: United States
  • 82 pages
  • GlobalData

FEATURED COMPANIES

  • Masimo Corp
  • Medtronic Plc
  • Nonin Medical Inc
  • Philips Respironics Inc
  • Vyaire Medical Inc
  • MORE
United States Respiratory Measurement Devices Market Outlook to 2025

Summary

This new report, United States Respiratory Measurement Devices Market Outlook to 2025, provides key market data on the United States Respiratory Measurement Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Respiratory Measurement Devices market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Respiratory Measurement Devices market.
  • Global corporate-level profiles of key companies operating within the United States Respiratory Measurement Devices market.
  • Key players covered include Medtronic plc, Masimo Corp, Nonin Medical Inc and others.
Reasons to Buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Masimo Corp
  • Medtronic Plc
  • Nonin Medical Inc
  • Philips Respironics Inc
  • Vyaire Medical Inc
  • MORE
2 Introduction
2.1 What Is This Report About?
2.2 Respiratory Measurement Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Respiratory Measurement Devices Market, United States
3.1 Respiratory Measurement Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Capnographs Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Pulse Oximeter Systems Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Spirometers Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Respiratory Measurement Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Capnographs Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Pulse Oximeter Systems Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Spirometers Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Respiratory Measurement Devices Market, United States, Average Price ($) , 2015-2025
3.4 Respiratory Measurement Devices Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Respiratory Measurement Devices Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Respiratory Measurement Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Masimo Corp
4.2.1 Company Overview
4.3 Nonin Medical Inc
4.3.1 Company Overview
4.4 Medical International Research Srl
4.4.1 Company Overview
4.5 Vyaire Medical Inc
4.5.1 Company Overview
4.6 Philips Respironics Inc
4.6.1 Company Overview
5 Respiratory Measurement Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Edwards Lifesciences Prices Public Offering of 4.3% Notes Due 2028 for USD600 Million
6.2 Equity Offerings
6.2.1 Edwards Lifesciences Plans to Raise up to USD34.5 Million in Public Offering of Shares
6.2.2 Soleno Therapeutics Files Registration Statement for Public Offering of Shares
6.2.3 Soleno Therapeutics to Raise USD15 Million in Private Placement of Shares and Warrants
6.3 Partnerships
6.3.1 Soleno Therapeutics and Capnia Form Joint Venture with OptAsia Healthcare
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 11, 2018: Natus Medical Announces Leadership Changes
7.1.2 May 09, 2018: AMETEK names Matthew Conti as vice president, human resources
7.1.3 May 09, 2018: AMETEK hires David Samyn as vice president and general manager for materials analysis division
7.1.4 Apr 02, 2018: ResMed Hires Bobby Ghoshal as First Chief Technology Officer
7.1.5 Feb 20, 2018: Mark Scheuer Elected Vice President, Environmental, Health & Safety
7.1.6 Jan 05, 2018: Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit
7.1.7 Nov 17, 2017: ResMed Elects Karen Drexler to Its Board of Directors
7.2 Financial Announcements
7.2.1 May 16, 2018: Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
7.2.2 May 11, 2018: Novartis Announces FDA Approval of Gilenya as the First Disease-modifying Therapy for Pediatric Relapsing Multiple Sclerosis
7.2.3 May 10, 2018: CASMED Reports First-Quarter 2018 Financial Results
7.2.4 May 02, 2018: Masimo Reports First Quarter 2018 Financial Results
7.2.5 May 02, 2018: AMETEK Announces Record First Quarter Results And Raises 2018 Guidance
7.2.6 Apr 26, 2018: ResMed Announces Results for the Third Quarter of Fiscal Year 2018
7.2.7 Apr 25, 2018: Natus Medical Announces First Quarter Financial Results
7.2.8 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
7.2.9 Apr 02, 2018: Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
7.2.10 Mar 14, 2018: CASMED Announces 2017 Fourth-Quarter and Full-Year Financial Results
7.2.11 Feb 27, 2018: The European Medicines Agency Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in Hereditary Angioedema Patients Aged 12 Years and Older
7.2.12 Feb 27, 2018: Masimo Reports Fourth Quarter 2017 Financial Results
7.2.13 Feb 07, 2018: Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results
7.2.14 Feb 01, 2018: AMETEK Announces Record Fourth Quarter and Full Year Results and Issues 2018 Guidance
7.2.15 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
7.2.16 Jan 22, 2018: ResMed Reports Second Quarter of Fiscal Year 2018 Financial Results
7.2.17 Jan 08, 2018: Natus Medical Announces 2018 Annual and First Quarter Financial Guidance
7.2.18 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
7.2.19 Nov 09, 2017: VBL Therapeutics to Present at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) on November 18
7.2.20 Nov 09, 2017: CASMED Reports Third-Quarter 2017 Financial Results
7.2.21 Oct 31, 2017: Masimo Reports Third Quarter 2017 Financial Results
7.2.22 Oct 26, 2017: ResMed Announces Results for the First Quarter of Fiscal Year 2018
7.2.23 Oct 25, 2017: Natus Medical Announces Third Quarter 2017 Financial Results
7.2.24 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
7.3 Legal And Regulatory
7.3.1 Oct 06, 2017: ResMed's European Patents Infringed by Fisher & Paykel in Germany
7.4 Other Significant Developments
7.4.1 Jun 26, 2018: InfuSystem Holdings Selected as an Official Distributor of CADD Infusion Therapy Products by Smiths Medical
7.5 Product News
7.5.1 Nov 27, 2017: Masimo Announces FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.3 Contact Us
8.4 Disclaimer

List of Tables
Table 1: Respiratory Measurement Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Respiratory Measurement Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Capnographs Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Capnographs Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Spirometers Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Spirometers Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Respiratory Measurement Devices Market, United States, Volume (Units), 2015-2020
Table 10: Respiratory Measurement Devices Market, United States, Volume (Units), 2021-2025
Table 11: Capnographs Market, United States, Volume (Units), 2015-2020
Table 12: Capnographs Market, United States, Volume (Units), 2021-2025
Table 13: Pulse Oximeter Systems Market, United States, Volume (Units), 2015-2020
Table 14: Pulse Oximeter Systems Market, United States, Volume (Units), 2021-2025
Table 15: Spirometers Market, United States, Volume (Units), 2015-2020
Table 16: Spirometers Market, United States, Volume (Units), 2021-2025
Table 17: Respiratory Measurement Devices Market, United States, Average Price ($), 2015-2020
Table 18: Respiratory Measurement Devices Market, United States, Average Price ($), 2021-2025
Table 19: Respiratory Measurement Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Respiratory Measurement Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Respiratory Measurement Devices Market Pipeline Products
Table 22: Edwards Lifesciences Prices Public Offering of 4.3% Notes Due 2028 for USD600 Million
Table 23: Edwards Lifesciences Plans to Raise up to USD34.5 Million in Public Offering of Shares
Table 24: Soleno Therapeutics Files Registration Statement for Public Offering of Shares
Table 25: Soleno Therapeutics to Raise USD15 Million in Private Placement of Shares and Warrants
Table 26: Soleno Therapeutics and Capnia Form Joint Venture with OptAsia Healthcare
Table 27: Total Number of Primary Research Participants, Anesthesia and Respiratory Devices Market, by Country

List of Figures
Figure 1: Respiratory Measurement Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Capnographs Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Spirometers Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Respiratory Measurement Devices Market, United States, Volume (Units), 2015-2025
Figure 6: Capnographs Market, United States, Volume (Units), 2015-2025
Figure 7: Pulse Oximeter Systems Market, United States, Volume (Units), 2015-2025
Figure 8: Spirometers Market, United States, Volume (Units), 2015-2025
Figure 9: Respiratory Measurement Devices Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
  • Medtronic Plc
  • Masimo Corp
  • Nonin Medical Inc
  • Medical International Research Srl
  • Vyaire Medical Inc
  • Philips Respironics Inc
Note: Product cover images may vary from those shown
Adroll
adroll